U.S. Markets open in 2 hrs 11 mins
  • S&P Futures

    3,816.75
    -8.75 (-0.23%)
     
  • Dow Futures

    30,900.00
    -33.00 (-0.11%)
     
  • Nasdaq Futures

    11,639.00
    -35.25 (-0.30%)
     
  • Russell 2000 Futures

    1,733.60
    -4.70 (-0.27%)
     
  • Crude Oil

    112.67
    +0.91 (+0.81%)
     
  • Gold

    1,828.00
    +6.80 (+0.37%)
     
  • Silver

    20.97
    +0.10 (+0.47%)
     
  • EUR/USD

    1.0531
    +0.0006 (+0.0527%)
     
  • 10-Yr Bond

    3.2060
    0.0000 (0.00%)
     
  • Vix

    28.92
    +1.97 (+7.31%)
     
  • GBP/USD

    1.2161
    -0.0023 (-0.1909%)
     
  • USD/JPY

    136.4620
    +0.3340 (+0.2454%)
     
  • BTC-USD

    19,981.43
    -1,006.17 (-4.79%)
     
  • CMC Crypto 200

    431.83
    -18.23 (-4.05%)
     
  • FTSE 100

    7,285.82
    -37.59 (-0.51%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

Flora Growth Appoints Cannabis Regulatory Veteran Holly Bell as Vice President of Regulatory Affairs

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FORT LAUDERDALE, Fla. & TORONTO, May 16, 2022--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today the appointment of regulatory veteran Holly Bell as Vice President of Regulatory Affairs. Bell will play a critical role in Flora’s domestic and global expansion strategy and lead government relations in key international markets.

Most recently, Bell was the Florida Department of Agriculture and Consumer Services’ first Director of Cannabis. This agency allowed for the creation of manufacturing, cultivation and sales programs in the state. As the Director of Cannabis, Bell worked with leading regulators throughout the state to create the first commercial hemp program in Florida and develop an extensive educational series on the program. She also advised leading financial institutions on compliance to help them offer banking services to cannabis businesses.

At Flora, Bell will oversee the regulatory strategy supporting the advancement of Flora’s cultivation, distribution and pharmaceutical programs including the Company’s regulatory submissions and interactions with government authorities worldwide. Bell will also work to develop and expand curriculum produced in partnership with EdEx that educates university students, companies and governments about the business of cannabis.

"I am excited to be working with Flora, supporting our work on the global stage, by advancing how the world views cannabis as a product and as a medicine," Bell said. "I’m looking forward to leveraging my experience launching Florida’s hemp program to help Flora improve access to some of the best wellness brands in the world. From our leadership and brand teams to our valued scientists and cultivators, every part of the Flora organization is dedicated to providing safe, legal and accessible cannabis products to consumers globally."

"Holly’s unique knowledge and understanding of the United States’ regulatory framework will position us to make thoughtful, educated and bold decisions regarding strategic distribution, cultivation and sales plans," said Luis Merchan, President and CEO of Flora Growth. "We look forward to bringing Holly’s expertise to our growing roster of industry standouts and working closely with governments worldwide to break down the barriers to the cannabis trade."

Before joining the Flora team, Bell worked as a cannabis consultant across the US, helping build the infrastructure for industrial hemp programs. Bell holds a bachelor’s degree in Agricultural Economics from Purdue University and is a tenured consultant with experience working in the entertainment, cannabis and banking spaces.

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; our environmental and sustainability practices and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220516005407/en/

Contacts

Investor Relations Contact:
James Williams
ir@floragrowth.com

Public Relations Contact:
Cassandra Dowell
+1 (858) 221-8001
flora@cmwmedia.com